Author

Isabel Arana

Observed name: I. Arana

Institutions: City Of Hope National Medical Center, City of Hope, Kaiser Permanente Bernard J. Tyson School of Medicine

Observed institutions: City Of Hope National Medical Center, Kaiser Permanente, City of Hope, Kaiser Permanente Bernard J. Tyson School of Medicine

ORCID: 0009-0009-9916-5449

Observed ORCID: 0009-0009-9916-5449

OpenAlex ID: A5116060140

Cutaneous toxicities associated with epidermal growth factor receptor and mesenchymal epithelial transition factor dual blockade via bispecific antibody amivantamab

2025 · Isabel Arana, Grant J. Riew, et al. · Journal of the American Academy of Dermatology · 9

Screening for comprehensive social needs in patients with cancer: a narrative review

2025 · Isabel Arana, Raymond Liu, et al. · JNCI Cancer Spectrum · 7

Evaluating lung cancer screening disparities in an integrated healthcare system: barriers and opportunities

2025 · Carmen Javier, Sheng-Fang Jiang, et al. · Frontiers in Oncology · 3

62955 Cutaneous toxicities associated with EGFR-MET bispecific antibody amivantamab

2025 · Isabel Arana, Grant Riew, et al. · Journal of the American Academy of Dermatology

A quality improvement study of gain-framed and loss-framed medication reminder emails to improve statin medication adherence

2025 · A.M. Yeung, M.T. Hukill, et al. · Annals of Epidemiology

Rare Concomitant Langerhans Cell Histiocytosis in a Patient With Folliculotropic Mycosis Fungoides

2025 · Cristo A. Carrasco Mendoza, Isabel Arana, et al. · Journal of Cutaneous Pathology

Rare Concomitant Langerhans Cell Histiocytosis in a Patient with Folliculotropic Mycosis Fungoides

2024 · Cristo Armando Carrasco Mendoza, Isabel Arana, et al. · Clinical dermatology and surgery.

Works count: 7

Citation count: 19

H-index: 3

I10-index: